Catherine Moukheibir - 15 Jun 2021 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
Director
Signature
/s/ Brian Tessler, Attorney-in-Fact
Issuer symbol
IRWD
Transactions as of
15 Jun 2021
Net transactions value
$0
Form type
4
Filing time
16 Jun 2021, 16:33:16 UTC
Previous filing
04 Jun 2021
Next filing
17 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRWD Class A Common Stock Award $0 +1,565 +2.2% $0.000000 73,325 15 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued pursuant to the Director Compensation Policy, effective May 2019.